Skip to content

Effect of Intradialytic Exercises in Chronic Kidney Disease Patients

Intradialytic Aerobic Versus Resistive Exercises on Immunity Response in Patients With Chronic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06293092
Enrollment
60
Registered
2024-03-05
Start date
2022-04-30
Completion date
2024-01-30
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease stage3

Keywords

Exercise, Dialysis, Kidney Failure, Chronic

Brief summary

the purpose of this study is to compare between intradialytic aerobic versus resistive exercises on immunity response in patients with chronic kidney disease.

Detailed description

The patients of this study will randomly assigned into three equal groups (n=20) 1. Study Group A (20 patients) will receive intradialytic aerobic exercise and medical treatment. 2. Study Group B (20 patients) will receive intradialytic resistive exercise and medical treatment. 3. Control Group C (20 patients) will receive medical treatment only (HD session and drugs) Each patient will receive the treatment program three times per week for three months.

Interventions

DEVICEleg pedaling cycling device

Intradialytic aerobic cycling exercise program ,each patient will receive the treatment program three times per week for three months.

DEVICEsand bags

Intradialytic resistive exercise program , each patient will receive the treatment program three times per week for three months.

hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

control group receive medical treatment only ,first study group receive medical treatment and intradialytic aerobic exercise , second study group receive medical treatment and intradialytic resistive exercise

Eligibility

Sex/Gender
MALE
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Sixty men chronic kidney disease (grade III RF). They received regular hemodialysis sessions at least one year ago, each one for four hours, three times per week. * They had a history of type II Diabetes more than five years. * Their age will be ranged from 50-60 years old. * They are Fit for exercise by functional assessment using six minute walk test. * Their Hemoglobin level more than 10 g\\dl. * Their Body Mass Index (BMI) will be ranged from 18.5 to 24.9.

Exclusion criteria

* Severe cardiac disorders. * Severe orthopedic problems (for example fractures). * Hepatic encephalopathy. * Preexisting neuromuscular diseases (e.g. myasthenia gravis). •Severe chest diseases. * Spinal cord injuries involved the phrenic nerve. * Uncontrolled diabetes or hypertension * Patients receiving inefficient hemodialysis session. * Patients with other cause for inflammation e.g. malignancy and autoimmune disease. * Active bleeding as alveolar hemorrhage, hemoptysis. * Physical limitation that would limit cycling.

Design outcomes

Primary

MeasureTime frameDescription
Concentration of immunoglobulin gbaseline , 12 weeks for each patientmeasured by mg/dl
Total leukocyte countbaseline , 12 weeks for each patientmeasured by (cell/mcl)\*\*\*\*1000
lymphocyte countbaseline , 12 weeks for each patientmeasured by (cell/mcl)\*\*\*\*1000
neutrophil countbaseline , 12 weeks for each patientmeasured by (cell/mcl)\*\*\*\*1000
Concentration of HbA1cbaseline , 12 weeks for each patientmeasured by percentage of blood sugar last 3 months

Secondary

MeasureTime frameDescription
hemoglobin concentrationbaseline , 12 weeks for each patientmeasured by (g/dl)
thrombocytes countbaseline , 12 weeks for each patientmeasured by (cell/mcl)\*\*\*\*1000
diastolic blood pressurebaseline , 12 weeks for each patientmeasured by mmHg
Systolic blood pressurebaseline , 12 weeks for each patientmeasured by mmHg
six minute walk testbaseline , 12 weeks for each patientmeasured by meter
(KDQOL-SFTM) questionnairebaseline , 12 weeks for each patientmeasured by scoring a score-value from 0 (worst health status) to 100 (best health status) was obtained

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026